Free Trial

Yield10 Bioscience Q3 2023 Earnings Report

Yield10 Bioscience logo
$0.02 0.00 (0.00%)
As of 04/4/2025

Yield10 Bioscience EPS Results

Actual EPS
-$9.84
Consensus EPS
-$7.44
Beat/Miss
Missed by -$2.40
One Year Ago EPS
N/A

Yield10 Bioscience Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Yield10 Bioscience Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Remove Ads

Yield10 Bioscience Earnings Headlines

Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
See More Yield10 Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Yield10 Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Yield10 Bioscience and other key companies, straight to your email.

About Yield10 Bioscience

Yield10 Bioscience (NASDAQ:YTEN) operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

View Yield10 Bioscience Profile

More Earnings Resources from MarketBeat